Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | VANGL1 |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → VANGL1 |
| (<<) CHST11 → VANGL1 |
| (<<) CNFN → VANGL1 |
| (<<) CYP1A2 → VANGL1 |
| (<<) DAB2 → VANGL1 |
| (<<) DHRS9 → VANGL1 |
| (<<) GLRX → VANGL1 |
| (<<) GNG5 → VANGL1 |
| (<<) GPX2 → VANGL1 |
| (<<) GSK3B → VANGL1 |
| (<<) LCP1 → VANGL1 |
| (<<) MAP3K6 → VANGL1 |
| (<<) NET1 → VANGL1 |
| (<<) NRAS → VANGL1 |
| (<<) PIK3R5 → VANGL1 |
| (<<) PTAFR → VANGL1 |
| (<<) RXRA → VANGL1 |
| (<<) STK40 → VANGL1 |
| (<<) TPM3 → VANGL1 |
| (<<) TUBA1C → VANGL1 |
| (<<) WWTR1 → VANGL1 |
| Downstream (Children) |
|---|
| VANGL1 → ELF3 (>>) |
| VANGL1 → GNAI3 (>>) |
| VANGL1 → ITGA7 (>>) |
| VANGL1 → KLF4 (>>) |
| VANGL1 → MEX3B (>>) |
| VANGL1 → NRIP3 (>>) |
| VANGL1 → TRIM32 (>>) |
| VANGL1 → VTCN1 (>>) |
